stars 1 stars 2 stars 3

Bioimplon is one of the leading companies specialized in the development and distribution of innovative and regenerative biomaterials for medical and dental fields. All of our products (bone substitute & collagen membranes) consist of Atelo-Collagen of bovine origin. Our membranes, matrices and haemostatics consist entirely of this modified, non-immunogenic collagen. Bioimplon invests continuously in the development of research and technology, so that our products are constantly being improved. As well, Bioimplon has competent and specialized staff in the medical field. We continuously expand our business and we offer our products worldwide in about 72 countries. Today Bioimplom is an innovative market leader in the natural bone and soft tissue regeneration sector.

Bioimplon GmbH Questions

The Bioimplon GmbH annual revenue was $5.2 million in 2026.

Bioimplon GmbH is based in Gießen, Hessen.

The NAICS codes for Bioimplon GmbH are [54171, 54, 541713, 5417, 541].

The SIC codes for Bioimplon GmbH are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users